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Ethics in a medical context have been defined by Professor Gordon Dunstan'
as "the obligations of a moral nature which govern the practice of medicine".
Ethics are expressed in the language ofduties: the duty in general to serve and
protect the interests of patients in ways consistent with the corporate ethics of
the profession, and the moral values held in common with society. These
duties, referred to as Hippocratic, must be worked out in particular cases by
moral reasoning.
The great majority oftransplantsworld-wide are kidneytransplants. The kidney
is duplicated and until recently it was the only solid organ which could be
transplanted from a living donor. However it is now possible totransplant a lobe
of liver or lung from a living donor, though as yet this is rarely done. I will deal
mainly withthe ethics concerned in renal transplantation as my ownexperience
lies there.
Over the past two decades, particularly since the introduction of continuous
ambulatory peritoneal dialysis (CAPD), the number of patients receiving
treatment for end-stage renal failure has increased rapidly. What follows
applies to westernized countries, but in the Third World the outlook for sufferers
with end-stage renal disease has not improved and most still die.
A Renal Replacement Programme is made up of the dialysis population and
those who have received a successful transplant. Together these make up the
stock of patients, expressed per mrillion population. The dialysis population
contains the patients accepted for treatment in the current year, estimated at
about 80 new patients /million/annum. This estimate resulted from two recent
British surveys, but the studies were based on mainly Caucasian populations.
Where the population contains significant numbers of Asians and Blacks the
incidence of renal failure is two to three times higher than in Caucasians, due
mainly to increase in Type 2 diabetes mellitus and hypertension. It may be as
high as 90 to 140 /million, according to the age specific demography of the
population. In 1992 only a few UK dialysis centres accepted as many as 80/
million and some asfew as50/million, despitepopulationscontainingsubstantial
numbers of the ethnic minorities.
The incidence of renal failure rises sharply with age. The table shows the age
specific acceptance rates in the Thames Regions for Whites, Blacks and
Asians, the rates forWhites being regarded as 1. The rapid rise in incidence with
increasing age is apparent.
The Ulster Medical Society, 1994.
Mary G McGeown, CBE, DSc(Hon), MD, PhD, FRCP, Professorial Fellow, Department ofMedicine,
The Queen's University of Belfast BT9 7AB.Ethics oforgan transplantation
FIGURE I
Average annual age specific acceptance rates onto renal replacement




Rate per 52.5 160.0 158.1
million
Relative rate 1.0 3.05 3.01
(95% CI) (2.30 - 4.04) (2.31 - 3.94)
55-64
Rate per 114.4 623.3 830.7
million
Relative rate 1.0 5.46 5.99
(95% CI) (3.62-8.24) (4.5-7.99)
65+
Rate per 119.1 922.7 952.0
million
Relative rate 1.0 7.76 8.01
(95% CI) (4.81-12.50) (5.18-12.4)
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The Dialysis Programme must provide treatment for patients remaining from
previousyears. About75-80%ofall patients surviveforatleastthreeyears after
treatment is commenced so that after a short span of years large numbers of
patients accumulate. Added to these are patients whose renal transplant has
failed. A "successful transplant " may not function for the remainder of the
patient's life - though some function well for many years. The patient with the
longest surviving cadaver kidney graft in the world, still functioning well after
28½/2 years, came from Belfast. Patients needing a second or even a third or
fourth graft must be added tothe accumulating numbers ofpatients on dialysis.
Patients exit from the Renal Replacement Programme by death, but this
accounts for only 20-25% of patients by three years. The death rate of older,
particularly diabetic patients is higher, perhaps 50% by three years. Voluntary
withdrawal from dialysis was very rare in the UK until the past decade. It now
accounts for some 5% ofdeaths on dialysis programmes, and recent data from
both Canada and the Europe suggest that as many as 25% of deaths may be
due to this cause. Exit by transplantation in the UK accounts for up to 38/
million/population/year. It is commonly supposed that there is a ceiling on
cadaver grafts available at about 40/million.
The ethical problems oftransplantation begin as soon as a patient is diagnosed
as having progressive, or near end stage renal failure. Each patient for whom
the need for renal replacement can be foreseen must be given a clear
understanding of the treatment to come. The benefit of rescue from death is
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obvious, but the arduous discipline needed for success, and the fact that it may
be for life, must be pointed out. Some may receive a successful transplant, but
this may not be available for the older and more disadvantaged patients. The
patient must appreciate the risks and the fact that the graft may fail. Before
entrance to the dialysis programme the patient must be fully informed. If a
transplant is planned, again a full explanation of all that is involved is needed.
Public confidence is essential for the development of a successful transplant
programme. The public must be satisfied that the procurement of organ donors
is ethical and that the distribution of organs is fairly carried out. For example
the development of organ transplantation in Japan was delayed by more than
25 years by the circumstances surrounding a heart transplant carried out in
Japan soon after Professor Barnard's first heart transplant. The transplant failed
and the public seem to have been left with deep suspicion of the propriety of
the diagnosis of death of the donor and the suitability of the recipient for
transplantation. Partly though not entirely as a result of this case, brain stem
death is not accepted as real death in Japan despite extensive discussion by the
public and by a series of committees to examine the question. Three years ago
a conference was held in Copenhagen to debate the issue of brain stem death,
followed by yet another Governmental Commission which reported in favour of
accepting brain stem death. However the bar council objected and the issue is
not yet resolved. 2
Kidneys and virtually all other solid organs used for transplantation, come from
recently dead cadavers. This accounts for the vast majority of donations.
Kidneys, much more rarely lobes of liver or lung, may be taken from living
related donors. Living unrelated persons become organ donors much less
frequently, the organ almost always being a kidney. A "domino" graft is an
organ which has been removed from a patient, as part ofhis/her own treatment,
which becomes available for transplantation into another patient. The heart
removed from one patient before a heart-lung transplant may become a
"domino graft" transplanted into a second patient, or the heart valves may be
used in the same way. Even an eye may be removed as part of therapy and the
cornea used for another patient. "Domino" organ grafts have become quite
common. These procedures produce many ethical problems which need
consideration.
In theUK the removal of human tissue for transplantation was governed by the
Human Tissue Act3 of 1961, until the passage ofthe Human Organ Transplant
Act4 in 1989. The donor of cadaver kidneys was dead in the traditional sense
that heart beat and circulation had ceased. The time that elapsed from the
cessation of heart beat until perfusion of the organs with cold perfusion fluid,
known as the "initial warm ischaemia time", was long, often 60 minutes or
more. Such kidneys did not produce urine for 10 days or longer, but their long
term function was often very good. The initial warm ischaemia time was 30
minutes or longer for 53 of the patients transplanted in Belfast 1968-1978.
90% ofthe grafts functioned, including all 20 ofthose in whom it was 60 minutes
or longer.5 However long warm ischaemia is clearly undesirable - kidneys with
short ischaemia function sooner, some with long ischaemia never function at
all. Very short initial warm ischaemia time is essential for heart, lung and liver
transplants, which are damaged by even short periods of anoxia.
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As knowledge of the management of patients in intensive care increased it
became apparent that when the brain stem ceases to function, spontaneous
respiration and the circulation cease within a short time. When these functions
are replaced by a ventilator the organs ofthe body continue to be perfused and
theirfunction ismaintained. Brain stem death is now almostgenerally accepted
as equivalent to true death, except in Japan. Criteria for brain stem death are
now established. Diagnosis of the cause of coma, exclusion of other causes of
deep coma -depressant drugs, primary hypothermia, metabolic andendocrine
disturbances, and specific tests of brain stem function are necessary before
"permanent functional death of the brain stem" can be diagnosed, while
respiration and circulation are being maintained. Further artificial support is
then fruitless and should be withdrawn. These criteria were not established by
law, but were described in detail in the Code of Practice6 for the removal of
cadaveric organs for transplantation drawn up by a Working Party on behalf of
the Department of Health in 1979 and revised7 in 1983. The timing of the
withdrawal ofartificial support is discretionary, and allows time for finding and
informing relatives. If the circumstances are suitable, discussion may take
placeabouttransplantation. Permissionforremoval oforgansmaybe requested.
If consent is forthcoming, simple blood tests are carried out and the transplant
team is mobilized. Ventilation is continued right up to the time of surgery for
removal of the organs. Under these circumstances initial warm ischaemia
approaches zero. Many kidneys obtained under these circumstances function
immediately, and heart, heart-lung and liver grafts may be obtained. Corneas
will tolerate very much longer ischaemia and may be harvested many hours
after death.
Consent for the use ofcadaver organs came to be regarded as the "Gift of Life"
as Sir Roy Calne 8 called it in his admirable book of that title in 1970. Virtually
all cadaver donors occur in NHS hospitals where the organs are taken following
the Code of Practice already mentioned. This has been accepted as ethical by
the transplant profession generally, including the British Transplantation
Society 9 and the international Transplantation Society.'0
During the late 1970s and 1980s a small number of cadaver kidneys were
imported into the UK from USA as being surplus to their requirements. The
arrangements were made by surgeons in this country directly with one or other
of the recognised US transplant organ agencies, which were presumed to be
following a similar code of practice. Almost all of these kidneys were used for
private patients, usually offoreign nationality, who were not eligible for kidneys
taken from NHS patients. The cost of these imported kidneys was too high for
the NHS even although the cost was supposedly restricted to that of removal
and transport of organs, plus a small contribution to the kidney retrieval
organization. Laterthis source ofkidneys, already diminished to a veryfew, was
brought under the supervision of UKTS.
The Codes of Practice 6, 7 ensure that all reasonable enquiries are made to
ensure that the wishes of the deceased are carried out. The wish to become a
donor may be clearly expressed by the carrying of a donor card and informing
the next-of-kin. If this is not available the next-of-kin is asked if the deceased
had expressed a view on organ donation. "All reasonable enquiries" must be
carried out to consult the next-of-kin. If such a person cannot be found the
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representative of the hospital may be empowered to give permission for
donation, but this is done very rarely in practice, and it is considered good
practice notto use such donors and risk being labelled "vultures" by the media.
The view ofthe spouse or co-habiting partner is ofthe greatest importance, but
other relatives may be contacted and their opinion obtained, as in particular
cases this may be very important to the family. In one case in which I was
involved, the young husband whose wife died as a result of a road traffic
accident followed the wishes of his mother-in-law, upon whom he would
depend for caring for their young infant - this in spite of the fact that he knew
that his wife had highly approved of organ donation. In another case the
husband of a very recently married couple died. The wife wished to follow the
view against donation expressed by the man's parents. In neither case did I
make any effort to persuade the next-of-kin to allow donation. To do so would
have been unethical.
The great majority of live donors are genetically related. Following the
demonstration of successful drug immunosuppression by Calne and Murray 1I
in Boston in 1962 most kidneys were taken from living related donors. The
kidney can be obtained under ideal circumstances from a healthy donor who
is not hypotensive before the organ is removed; the period ofischaemia is very
brief and urine is usually produced almost immediately, often during surgery.
In most early cases relationship was close and of the first degree. Only ABO
matching was available, but it was known that other antigens must be of
importance and might be expected to match when grafts were exchanged
between closely related individuals, especially between siblings. The use of
living related donors was extensive in the US andin some European countries.
They were notusedextensivelyinUK, andtheirusehasdiminishedprogressively
during the past decade as numbers of cadaver kidneys have slowly increased.
In Belfast living related donors have been used for only 54 of our total of 762
kidney grafts. Living donors are still used quite frequently in Scandinavia and
some other European countries. Westlie et al.12 stated recently that the use of
living relateddonors is still an integral partofthe Norwegian national programme
for treating end stage renal disease.
In the past the use of a living genetically related donor has been accepted as
ethical almost without question. Doctors have accepted naively that blood
relationship ensures that donation is voluntary and altruistic, and that coercion
does not occur. Perhaps they have been wilfully blind on this issue ! Donation
from a parent to a child is usually truly altruistic, but it may be otherwise. One
such "volunteer" donor was the father of a 28 year-old man. Both ofthe man's
parentswerealive andtherewas onebrother, a priest. Allthreewereinterviewed
together, and all expressedwillingness togive a kidney, butthe mothersaid she
had high blood pressure and a bad heart. She and the brother had a different
ABO group to the patient, which would have excluded them in any case, but the
father's group was similar. When the father was admitted to hospital for full
work-up, he confided thatduringhisyouth he hadnearly diedunderanaesthesia
when undergoing appendicectomy. He had been told that he would not survive
another anaesthetic, and believed he would die during the operation for
donation of a kidney. The situation was complicated by the fact that he was a
Protestant who had married a Roman Catholic and the sons had been brought
up in the Catholic faith. He felt that his wife would attribute his failure to give
© The Ulster Medical Society, 1994.
36Ethics oforgan transplantation
a kidney to his son to the religious difference, and would never forgive him. He
preferred to risk death he regarded as certain and go ahead with the donation.
Iarrangeda intravenouspyelogram andledthefathertobelievethathiskidneys
were unsuitable. The ethics of this you can decide for yourself ! There was a
good ending, as a cadaver graft was found which was a long term success.
The use of a sibling donor greatly increases the chance of an identical HLA
match, and all available siblings are often matched with the recipient. This
assumes that they are all true volunteers. I have known of several cases where
a member ofthe family had emigrated many years before to USA or Australia,
and there developed renal failure. The doctors responsible for treating the far-
away patient, contacted the siblings in Ireland with the request that their blood
group and tissue type should be done to see if they matched their patient. In
some cases the recipient had not seenthe family nor even written frequently for
long periods. There were the wives and children, sometimes still young, to be
considered. In one such case, there was a sister who was an identical match,
who had recently become engaged to be married. After lengthy discussions on
at least five occasions, sometimes with the fiance present, in spite ofthe man's
objection the sister went to the USA to see her brother. I never heard the
outcome ! In the case of a patient in Australia, there were three brothers and a
sister here who all offered to give a kidney. Interviewed separately, the sister
was apparently very anxious to give her kidney, but each of the brothers said
she must not be the donor as she was effectively a single parent responsible for
four young children, while her husband served a long jail sentence. In fact she
could not be the donor as she was hypertensive, weighed 20 stone, and had a
different ABO group. The three brothers were each HLA and ABO identical with
the patient in Australia. They drew straws as to who should be the donor, but
only on condition that their brother should travel to Belfast for surgery.
Other family members may be chosen by the family to become the donor. A
maiden aunt orcousin without dependant relative may be thought very suitable
by the other family members. "Aunt Jane" is in fact being coerced into
donation, unable to refuse to rescue the patient. In other cultures they may be
offered money or a bribe in kind. Close enquiry must be made to ensure that
family donation is truly altruistic. The really difficult situation arises when a
living unrelated donor is proposed. The events which led up to the Human
Organ Transplant Act in 1989 are very relevant here.
By the early 1980s most doctors accepted brain stem death as somatic death,
but a vociferous few did not. Also the transplant profession became worried
about rumours that donors had been brought from poor countries where renal
replacement therapy was not available, and paid paltry sums to undergo
surgery for the benefit of wealthy patients. It was alleged that London was a
centre for this illegal trade, which was condemned by both the British
Transplantation Society and the Transplantation Society. The British
Transplantation Society became worried thatthese rumours ofcommercialism
in live donation might have some foundation in fact. In 1985 the Society
published its own guidelines 9 onthe useofliving donors intheUnited Kingdom.
The General Medical Council signified its approval of the profession's effort to
regulate its own affairs. The British Transplantation Society asked also for a
Register of all transplants to be set up, but in spite of much pressure by their
Ethical Subcommittee, the Department of Health refused further legalisation.
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This was said this was not to be necessary, and would erode the freedom of
doctors.
These negotiations with the Department ofHealth were still continuing when in
January, 1989, the media published details of kidneys which were purchased
from Turkish donors and transplanted in the Humana Hospital in London. This
was followed by the hasty passage of the Human Organ Transplant Act at the
end of July, 1989.
Under the Act 4 it is an offence to make or receive payment for the supply, or
the offer of the supply, of an organ which has been or is to be removed from a
dead or living person, and is intended to be transplanted into another person
whether in Great Britain orelsewhere. Payment is defined as payment in money
or money's worth. The cost of removing, preserving and transporting the
organs, and expenses or loss of earnings which may be directly attributed to
supplyingthe organ from the donor's body are allowed. Advertisements forthe
supply oforgans are prohibited. The Act expressly permits donations oforgans
from persons within defined degrees of genetic relationship, and specifies the
ways in which the relationship is to be established. A person is genetically
related to his natural parents and children, his brothers and sisters ofthe whole
or half blood, the brothers and sisters ofthe whole or half blood of either of his
natural parents, and the natural children ofhis brothers and sisters ofthe whole
or half blood of either of his natural parents (i.e. genetic relationships are
acceptable only as far out as first cousins). Donations from donors more
distantly related than those permitted under the Act may be permitted with
certain restrictions. Proposals for such donations must be referred to a new
statutory body, the Unrelated Live Transplant Regulatory Authority, known as
ULTRA, for approval. This Authority has 1 1 or 12 members, appointed by the
Government, its Chairman being a medically qualified person not engaged in
transplantation. The Authority reports regularly to the Secretary of State for
Health.
The Act is given effect by a series of detailed regulations. The Authority has
prepared a booklet giving advice to clinicians about referral of proposals to it,
and has revised the booklet in the light oftheir experience ofdifficulties brought
up in individual cases. The Act also established a Register requiring a record
of all transplants carried out to be kept. The Register is currently maintained at
UKTSS, and is periodically reviewed. Prosecutions under the Act shall be
instituted by the Director of Public Prosecutions. The Act came into effect for
England and Wales in 1989, and by Order in Council, in Northern Ireland in
December, 1990. Cases must be referred to ULTRA if the genetic relationship
claimed is not confirmed by testing, if the relationship claimed is outside that
allowed by the Act, or if the donor is unrelated.
Experts in tissue typing are not satisfied with the tests for genetic relationship
defined in the Regulations. At present the tests must be personally carried out
by recognised testers registered on an official list. The tests prescribed are now
out ofdate, cumbersome and no longer in regular use in most laboratories, and
many of the recognised testers no longer perform them. Moreover such tests
cannot prove relationship, only suggest that it is likely. I may say that
Government hasrecognisedthatthe Regulationsfortesting genetic relationship
are inadequate and that revision is needed.
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Cases may also be referred to ULTRA because the donors are claimed to have
a genetic relationship less close than the full cousin relationship defined in the
Act. The tests prescribed are of no value in these circumstances. These cases
have not been British Nationals, and in the Third World "cousin" may be
interpreted very liberally! Evidence of a lasting emotional relationship is
sought, but it is very difficult to obtain satisfactory evidence. For practical
purposes they have to be regarded as essentially similar to unrelated living
donors.
The last category covered by the Act is the unrelated donor. The most frequent
unrelated donoristhespouseorlive-in partnerofthe recipient. Iftherelationship
concerned is a true life partnership, this donation is almost always truly
altruistic. The emotional bonding is deep and lasting, the donor has much to
gain if the sick partner is returned to health - their life style often improves
greatly. Howeveritisnecessarytomake certain thatthemarriageorrelationship
is not one of convenience made for the purpose of procuring a donor. In this
country it is easy to ascertain the duration of the relationship, but this may be
less easy when a patient comes to the UK for the purpose of the transplant,
accompanied by a spouse donor. Families from the Third World sometimes
come here with a "family friend". This type ofdonor is very difficult to evaluate.
Payment in money or kind may seem to be very likely, especially when the
donor and recipient belong to different social classes. Our purpose is to prevent
exploitation of the donor, but our understanding of their world is incomplete.
One of the ULTRA members has worked in Africa and his opinion is often
valuable. He has suggested that there may have been the hidden exchange of
a "bride price", which may have been the only way a poor young man may
obtain a wife - while providing a life-line to a wealthy member of his tribe.
Bedouin arabs regard the members of their own tribe as blood brothers, and
although fully informed ofrisks inherent in transplantation, say ifthey die in the
procedure itisAllah's will and a Passportto Paradise. India is different again and
there have been many reports of exploitation of the poor in Bombay and
Calcutta.
There have been occasional donors who were not known personally to the
recipient. One such case was that of a much loved bishop in an African
country.13 When his almost end-stage renal failure was known in his church, a
number of young men volunteered to give a kidney, and one was selected to
bethe donor. He came to London with the recipient and although previously not
known to him lived as a member of the family while awaiting transplantation.
This occurred before the Act, but the Ethical Committee of the British
Transplantation Societywasveryuneasyaboutthealmosthysterical enthusiasm
these circumstances had generated.
Lastly, in the USA kidneys were occasionally taken from convicts serving long
sentences. It was alleged that there was no remission of sentence or other
payment. These procedures were later admitted to be unethical. More recently
there have been reports of the use of organs taken from executed criminals in
China, 14 which must be regarded as unethical.
These case histories show why it has become necessary to require a report
made by an independent third party who has interviewed both the donor and
recipient, each being interviewed separately. The independent third party is
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acting in an altruistic capacity to protect the interest of the prospective donor.
The report must be sent direct to ULTRA, not via the clinician making the
proposal. The third party must be acceptable to ULTRA for this purpose, and
must be an NHS consultant physician, surgeon or psychiatrist, or someone of
equivalent professional status, who is not otherwise party to the transplant
proceedings nor a close associate of one who is. He or she should not be
practising in renal medicine or renal transplantation.
ULTRA reports directly to the Secretary of State for Health. Over the last two
years ULTRA has approved nearly 500 applications, the over-whelming
majority being "domino grafts", mainly hearts and heart valves, with a few
corneas. Kidney cases account for less than 10 per year. Each application is
sent to the Administrative Secretariat of ULTRA at the Department of Health,
who ensures that the documentation is complete, then forwards it to a panel of
three members, led by one ofthe clinicians on ULTRA. Every effort is made to
process the applications quickly. Very rarely it is necessary to hold over a
decision until a meeting of the Authority, though each case is reviewed at the
nextmeeting. OnthewholetheActhas regulatedeffectivelythetransplantation
of solid organs. Bone marrow grafts are not included.
As well as being satisfied that donor organs are obtained in an ethical way, the
public must be satisfied that available organs are distributed fairly. This is not
covered by the Human Transplant Act, and is a matter for doctors to regulate.
A perfect system for this does not exist. In UK and in most developed countries
where transplantation is a regular procedure, patients with information oftheir
blood group and tissue type are entered on a computerised recipient list. When
organs become available details ofthe donor, including blood group and tissue
type are reported, nowadays by Fax, to the organ distribution centre. The best
recipient match or matches are found by computer. When the tissue type is a
common one there may be a number of well matched, even identically
matched, possible recipients. In this situation, or if there are only less good
matches where the tissue type is a poorerprognostic tool, other principles must
be invoked. Apart from ABO group and tissue type match, the principles which
may be used are as follows: 15
* Give organs to those most in need - the "rescue principle"
- not a good idea
unless there is reasonable chance of a good outcome.
* Give organs to those have had a failed transplant - the "fidelity principle".
* Allocate by random choice - the "lottery".
* Priority to the longest on waiting list - "first come, first served" - seen asjust
by patients but may ignore important clinical points.
* Allocate by ability to pay -- not acceptable to us but is the main principle in
countries where mandated health insurance is not backed by government.
* Allocation by other parameters ofsocial worth - the system used to allocate
dialysis in the 1960s - unjust.
* Lobbying by press and media - also unjust, but often used.
* Allocation by tissue match grade - accepted by the public as just.
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There are no simple solutions for the ethical dilemmas which ensue. There is
also the hidden agenda concerning the fair distribution of organs between
centres. Rules to ensure this were set up by the Management Committee of
United Kingdom Transplant Service and modified many times over the years.
The United Kingdom Transplant Support Service Authority which succeeded
the Management Committee, is faced with the same difficulty in trying to agree
principles which would ensure "fair shares for all ".
France had a similar non-profit organisation run by doctors, with its own
guidelines for collecting organs, managing the national waiting list, and
allocating organs according to tissuecompatibility and other parameters. They
ran into difficulties recently when the French Inspectorate General of Health
noted that a large number of organs were allocated to non-resident foreigners,
especially Italians. Some irregularities in the collection of organs were also
reported. This has resulted recently in a plan to place transplantation in France
more firmly under state control. Their Minister of Health, Dr Douste-Blazy,'6
has said that there is no question ofplacing transplant physicians underfinicky
restrictions (his words) but controls were necessary to guarantee equal access
to organs for all patients.
The one type oforgan that remains to be considered is the xenograft. No other
human is involved, avoiding many of the ethical objections which have been
outlined, but some may object to receiving tissues from an animal on religious
grounds. Unfortunately when an animal tissue is grafted into a human the body
rapidly destroys the graft, even iftaken from a closely related primate species
such asthe baboon. In 1965-66 Reemtsma, thenworking in NewOrleanswhere
hehadaccesstotheLouisiana chimpresearchcentre, transplantedachimpanzee
kidney into a woman. The kidney survived for over nine months, ofcourse with
heavy immunosuppression. As he pointed out at the time, this was not a
breakthrough -the chimpanzee is an endangered species very difficult to breed
in captivity. Baboon kidneys were tried then with no success and recent
attempts using improved immunosuppression have not fared better.
Although attempts to transplant these closely related, so called concordant
species have not been successful, much effort is now being put into the
possibility of using pig organs. The pig kidney is about the right size and the
animal is easy to breed and matures quickly, butisgeneticallyfarremovedfrom
the human. In such discordant species rejection of transplanted tissue is
immediate and catastrophic. The rejection is mediated by complement. Much
research has centred on the idea that human anti-complementary proteins can
be injected into the pig genome to produce transgenic pigs. There are immense
difficulties still to be overcome before it becomes possible to use transgenic
pigs as a source of organs for human transplantation. It is not known how they
would function in a different species. Calne 17 stated recently that he believes
that clinical xenografting will become possible, but he and other eminent
transplanters think that this development is at least a decade away.
In the 1993 Audit of Renal Transplantation 18 (UKTSS) the UK national rate for
kidney transplantation is 29/million/year. Two centres, one being Northern
Ireland, reached 38/million/year in 1992. The figures included a small number
ofliving related grafts and two spouse grafts, amounting to a maximum ofabout
50 out of the approximately 1900 grafts performed in the year.
© The Ulster Medical Society, 1994.
41The Ulster Medical Journal
Figure 2 shows the number ofkidneys per million population obtained by each
region in 1991, the range being 17.5 to 49.4. Only five of the 18 regions
exceeded30 permillion. Thiswidevariation between centresmakesitprobable
that the remaining 13 regions could obtain more donors.
FIGURE II
Cadaveric kidney regional retrieval rates per million population reported to
UKTSSA. 21
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The Exeterstudy by Feest andcolleagues19 has shown that some patients dying
outside intensive care units could be used as donors. My own view is that
kidneys can be harvested from non-heart beating donors. It is more difficult to
organize the team for this, and post-transplant dialysis is usually necessary -
but this source served us well until we began to use heart-beating donors in
1976.
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Every effort must be used to increase the contribution oftransplantation to the
treatment end-stage renal failure. Organs for donation are a national resource
and must be used wisely. Meticulous observance of ethical principles is
essential to ensure public confidence. Informed use of the knowledge bought
by experience in matching kidneys with donors, andwelljudged pre-transplant
assessment of patients with renal failure are essential. The Holy Grail of the
perfect method of immunosuppression has yet to be found 20 21. We can hope
for better, and the immunosuppression available at present must be used with
great care. I personally would be reluctant to search for more live donors.
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